Cyclacel Pharmaceuticals Inc (CYCC)
1.805
+0.06
(+3.14%)
USD |
NASDAQ |
Apr 23, 16:00
1.805
0.00 (0.00%)
After-Hours: 18:24
Cyclacel Pharmaceuticals Price to Book Value: 3.920 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 3.801 |
| April 19, 2024 | 3.866 |
| April 18, 2024 | 4.018 |
| April 17, 2024 | 4.257 |
| April 16, 2024 | 3.627 |
| April 15, 2024 | 3.410 |
| April 12, 2024 | 3.822 |
| April 11, 2024 | 4.213 |
| April 10, 2024 | 4.452 |
| April 09, 2024 | 4.583 |
| April 08, 2024 | 4.583 |
| April 05, 2024 | 4.561 |
| April 04, 2024 | 4.762 |
| April 03, 2024 | 4.756 |
| April 02, 2024 | 4.604 |
| April 01, 2024 | 4.452 |
| March 28, 2024 | 4.582 |
| March 27, 2024 | 4.257 |
| March 26, 2024 | 4.170 |
| March 25, 2024 | 4.648 |
| March 22, 2024 | 4.752 |
| March 21, 2024 | 4.735 |
| March 20, 2024 | 4.886 |
| March 19, 2024 | 5.104 |
| March 18, 2024 | 5.451 |
| Date | Value |
|---|---|
| March 15, 2024 | 5.278 |
| March 14, 2024 | 5.421 |
| March 13, 2024 | 5.625 |
| March 12, 2024 | 5.388 |
| March 11, 2024 | 5.473 |
| March 08, 2024 | 5.734 |
| March 07, 2024 | 5.408 |
| March 06, 2024 | 5.147 |
| March 05, 2024 | 5.625 |
| March 04, 2024 | 5.864 |
| March 01, 2024 | 6.298 |
| February 29, 2024 | 5.560 |
| February 28, 2024 | 5.820 |
| February 27, 2024 | 5.907 |
| February 26, 2024 | 6.081 |
| February 23, 2024 | 5.755 |
| February 22, 2024 | 5.712 |
| February 21, 2024 | 5.896 |
| February 20, 2024 | 6.364 |
| February 16, 2024 | 6.448 |
| February 15, 2024 | 5.788 |
| February 14, 2024 | 5.584 |
| February 13, 2024 | 5.408 |
| February 12, 2024 | 5.342 |
| February 09, 2024 | 4.952 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2551
Minimum
Dec 28 2022
6.448
Maximum
Feb 16 2024
1.107
Average
0.7793
Median
Price to Book Value Benchmarks
| Corvus Pharmaceuticals Inc | 1.952 |
| Oragenics Inc | 3.072 |
| Relmada Therapeutics Inc | 1.373 |
| Alpine Immune Sciences Inc | 12.89 |
| MAIA Biotechnology Inc | 105.60 |
Price to Book Value Related Metrics
| Price | 1.805 |
| Earnings Yield | -1.48K% |
| Market Cap | 2.380M |